Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis [3]

British Journal of Ophthalmology

Volumn 91, Issue 10, 2007, Pages 1414-

  Freidlin, Julie ^a   Wong, Ira G ^a   Acharya, Nisha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYCLOPHOSPHAMIDE; DOXYCYCLINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; RITUXIMAB; STEROID;

BLURRED VISION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; HEMORRHAGIC CYSTITIS; HUMAN; KERATITIS; LETTER; PANCYTOPENIA; PRIORITY JOURNAL; SCLERITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, MONOCLONAL; CORNEAL ULCER; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 34848868782     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.113316     Document Type: Letter

References (5)

1. Stasi R, Stipa E, Del Poeta G, et al. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology 2006;45:1432-6.
2. Lim L, Suhler EB, Smith JR. Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol 2006;34:365-7.
3. Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005;257:540-8.
4. Smolen JS, Emery P, Keystone EC, et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis, 2007;66, 143-50.
5. Cheung CM, Murray PJ, Savage CO. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab. Br J Ophthalmol 2005;89:1542.